Cargando…
Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Guselkumab
Autores principales: | Jung, Jang Hwan, Jeong, Sun Mun, Kwon, Do Ik, Seong, Seol Hwa, Kim, Joon Hee, Park, Jong Bin, Suh, Kee Suck, Jang, Min Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608383/ https://www.ncbi.nlm.nih.gov/pubmed/37853900 http://dx.doi.org/10.5021/ad.21b.064 |
Ejemplares similares
-
Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective
por: Yamamoto, Toshiyuki
Publicado: (2021) -
Palmoplantar Pustulosis Induced by both Adalimumab and Golimumab for Treatment of Ankylosing Spondylitis
por: Seol, Jung Eun, et al.
Publicado: (2016) -
Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial
por: Terui, Tadashi, et al.
Publicado: (2019) -
Recent advances in palmoplantar pustulosis
por: Brunasso, Alexandra Maria Giovanna, et al.
Publicado: (2021) -
Sustained efficacy and safety of guselkumab in patients with palmoplantar pustulosis through 1.5 years in a randomized phase 3 study
por: Okubo, Yukari, et al.
Publicado: (2021)